UnitedHealth Group (NYSE: UNH) recently received a number of ratings updates from brokerages and research firms:

  • 9/1/2017 – UnitedHealth Group was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating.
  • 8/29/2017 – UnitedHealth Group had its “buy” rating reaffirmed by analysts at Cantor Fitzgerald.
  • 8/24/2017 – UnitedHealth Group had its “overweight” rating reaffirmed by analysts at UBS AG.
  • 8/18/2017 – UnitedHealth Group had its “buy” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $215.00 price target on the stock.
  • 8/17/2017 – UnitedHealth Group had its price target raised by analysts at Morgan Stanley from $210.00 to $215.00. They now have an “overweight” rating on the stock.
  • 8/11/2017 – UnitedHealth Group had its “outperform” rating reaffirmed by analysts at Cowen and Company. They now have a $220.00 price target on the stock, up previously from $175.00.
  • 8/1/2017 – UnitedHealth Group was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $215.00 price target on the stock. According to Zacks, “UnitedHealth Group’s robust Government business and continued strong growth at Optum are driving long-term growth. Its international business, growing membership and strong capital position are the other positives. In the most recently reported quarter, the company reported better-than-expected earnings, driven by an increase in revenues and membership. Encouraged by its impressive first-half earnings, the company raised the 2017 guidance, which instilled investors’ confidence in the company. Though its shares have slightly  underperformed ine industry year till date slightly it is not much of a concern for us given the company’s strong business fundamentals and earnings guidance given recently, will add momentum to the company’s shares in the coming quarters.”
  • 7/31/2017 – UnitedHealth Group was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “UnitedHealth Group’s robust Government business and continued strong growth at Optum are driving long-term growth. Its international business, growing membership and strong capital position are the other positives. In the most recently reported quarter, the company reported better-than-expected earnings, driven by an increase in revenues and membership. Encouraged by its impressive first-half earnings, the company raised the 2017 guidance, which instilled investors’ confidence in the company. Nevertheless, year to date, the company’s shares have underperformed the industry. Moreover, the company has reduced its exposure to the troubled public exchange business. Though this move will shield it from losses in this business, premium revenues are likely to be affected. Charges related to Penn Treaty are also concerns.”
  • 7/22/2017 – UnitedHealth Group had its “outperform” rating reaffirmed by analysts at Sanford C. Bernstein. They now have a $210.00 price target on the stock, up previously from $190.00.
  • 7/21/2017 – UnitedHealth Group had its “outperform” rating reaffirmed by analysts at Oppenheimer Holdings, Inc.. They now have a $205.00 price target on the stock, up previously from $203.00.
  • 7/21/2017 – UnitedHealth Group had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $208.00 price target on the stock.
  • 7/20/2017 – UnitedHealth Group had its “buy” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $212.00 price target on the stock.
  • 7/19/2017 – UnitedHealth Group was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating.
  • 7/19/2017 – UnitedHealth Group had its “positive” rating reaffirmed by analysts at UBS AG. They now have a $213.00 price target on the stock, up previously from $194.00.
  • 7/19/2017 – UnitedHealth Group had its price target raised by analysts at Citigroup Inc. from $195.00 to $213.00. They now have a “buy” rating on the stock.
  • 7/19/2017 – UnitedHealth Group had its price target raised by analysts at Barclays PLC from $200.00 to $217.00. They now have an “overweight” rating on the stock.
  • 7/18/2017 – UnitedHealth Group was given a new $235.00 price target on by analysts at Mizuho. They now have a “buy” rating on the stock.
  • 7/14/2017 – UnitedHealth Group had its price target raised by analysts at Bank of America Corporation from $210.00 to $214.00. They now have a “buy” rating on the stock.
  • 7/14/2017 – UnitedHealth Group had its “buy” rating reaffirmed by analysts at Cowen and Company.
  • 7/13/2017 – UnitedHealth Group had its “outperform” rating reaffirmed by analysts at Credit Suisse Group. They now have a $200.00 price target on the stock, up previously from $195.00.
  • 7/13/2017 – UnitedHealth Group had its price target raised by analysts at Deutsche Bank AG from $187.00 to $197.00. They now have a “buy” rating on the stock.
  • 7/10/2017 – UnitedHealth Group had its “outperform” rating reaffirmed by analysts at Sanford C. Bernstein. They now have a $190.00 price target on the stock.
  • 7/8/2017 – UnitedHealth Group was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded down 0.595% on Wednesday, reaching $198.125. The company had a trading volume of 1,622,734 shares. The company’s 50 day moving average price is $193.42 and its 200-day moving average price is $178.95. The stock has a market capitalization of $191.56 billion, a P/E ratio of 23.802 and a beta of 0.63. UnitedHealth Group Incorporated has a 1-year low of $132.39 and a 1-year high of $200.44.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same period in the prior year, the company posted $1.96 earnings per share. Equities analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Friday, September 8th will be issued a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.51%. UnitedHealth Group’s dividend payout ratio is currently 35.13%.

In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the transaction, the director now directly owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the transaction, the director now directly owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The disclosure for this sale can be found here. Corporate insiders own 0.89% of the company’s stock.

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.